Community Health Systems, Inc. (CYH) Income Statement

The reported revenue run-rate has been essentially flat across most of the ten-quarter window, with the 2026Q1 spike to $12.2B and subsequent drop to $2.8B appearing to reflect reporting or consolidation effects rather than organic demand. Investors should monitor whether these discontinuities reflect true portfolio changes, as the underlying growth trend remains difficult to isolate from the reported series. Without clearer disclosure of divestitures or acquisitions, the growth durability cannot be confidently assessed.

The stable 40-43% gross margin range through 2024 and most of 2025 appears consistent with a labor and supply-intensive facility model, but the extreme deviations in 2025Q4 and 2026 quarters suggest the COGS line is not comparable across periods. The reported figures do not allow us to determine whether pricing power has changed, and comparisons against peers such as HCA at 41.5% and THC at 82.3% should be treated cautiously given differing reporting definitions. Further investigation of cost line presentation is warranted before drawing margin conclusions.

Operating income does not scale consistently with gross profit, as the 2024 period shows modest margins while the 2025Q4 and 2026Q1 periods show outsized operating swings tied to SG&A figures that appear inconsistent with the revenue base. This pattern suggests the operating line may contain items unrelated to ongoing operations. The lack of R&D reporting is expected for a healthcare services provider, so overhead efficiency should be judged on SG&A trends, which are themselves erratic.